U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT06961448) titled 'A Study in Adults Evaluating Polycaprolactone Microsphere Filler for Treatment of Moderate to Severe Nasolabial Folds' on April 29.

Brief Summary: The goal of this clinical trial is to evaluate the safety and efficacy of polycaprolactone microsphere filler (Lafullen) for the correction of moderate to severe nasolabial folds in adults aged 18 and above, regardless of gender.

The main questions it aims to answer are:

* Does Lafullen improve wrinkle severity in the nasolabial fold area at 48 weeks post-injection (WSRS responder rate)?

* Is Lafullen superior to the control product (Restylane, a hyaluronic acid filler) in terms of long-...